111 related articles for article (PubMed ID: 15655803)
1. Direct injection of plasmid DNA into the skin induces dermatitis by activation of monocytes through toll-like receptor 9.
Sawamura D; Abe R; Goto M; Akiyama M; Hemmi H; Akira S; Shimizu H
J Gene Med; 2005 May; 7(5):664-71. PubMed ID: 15655803
[TBL] [Abstract][Full Text] [Related]
2. TLR9-dependent systemic interferon-beta production by intravenous injection of plasmid DNA/cationic liposome complex in mice.
Yoshida H; Nishikawa M; Yasuda S; Mizuno Y; Toyota H; Kiyota T; Takahashi R; Takakura Y
J Gene Med; 2009 Aug; 11(8):708-17. PubMed ID: 19462411
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation by a DNA/cationic liposome complex requires endosomal acidification and TLR9-dependent and -independent pathways.
Yasuda K; Ogawa Y; Yamane I; Nishikawa M; Takakura Y
J Leukoc Biol; 2005 Jan; 77(1):71-9. PubMed ID: 15496451
[TBL] [Abstract][Full Text] [Related]
4. TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.
Babiuk S; Mookherjee N; Pontarollo R; Griebel P; van Drunen Littel-van den Hurk S; Hecker R; Babiuk L
Immunology; 2004 Sep; 113(1):114-20. PubMed ID: 15312142
[TBL] [Abstract][Full Text] [Related]
5. Activation of toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation.
Johnson AC; Heinzel FP; Diaconu E; Sun Y; Hise AG; Golenbock D; Lass JH; Pearlman E
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):589-95. PubMed ID: 15671286
[TBL] [Abstract][Full Text] [Related]
6. CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation.
Obermeier F; Dunger N; Strauch UG; Hofmann C; Bleich A; Grunwald N; Hedrich HJ; Aschenbrenner E; Schlegelberger B; Rogler G; Schölmerich J; Falk W
Gastroenterology; 2005 Sep; 129(3):913-27. PubMed ID: 16143131
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of intrinsic immunogenicity of reporter and insulin gene therapy plasmids.
Ratanamart J; Huggins CG; Kirby JA; Shaw JA
J Gene Med; 2007 Aug; 9(8):703-14. PubMed ID: 17595049
[TBL] [Abstract][Full Text] [Related]
8. Bacterial DNA activates human neutrophils by a CpG-independent pathway.
Trevani AS; Chorny A; Salamone G; Vermeulen M; Gamberale R; Schettini J; Raiden S; Geffner J
Eur J Immunol; 2003 Nov; 33(11):3164-74. PubMed ID: 14579285
[TBL] [Abstract][Full Text] [Related]
9. Non-CpG-containing antisense 2'-methoxyethyl oligonucleotides activate a proinflammatory response independent of Toll-like receptor 9 or myeloid differentiation factor 88.
Senn JJ; Burel S; Henry SP
J Pharmacol Exp Ther; 2005 Sep; 314(3):972-9. PubMed ID: 15919763
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
11. Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9.
Knuefermann P; Schwederski M; Velten M; Krings P; Ehrentraut H; Rüdiger M; Boehm O; Fink K; Dreiner U; Grohé C; Hoeft A; Baumgarten G; Koch A; Zacharowski K; Meyer R
Cardiovasc Res; 2008 Apr; 78(1):26-35. PubMed ID: 18194990
[TBL] [Abstract][Full Text] [Related]
12. TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines.
Tudor D; Dubuquoy C; Gaboriau V; Lefèvre F; Charley B; Riffault S
Vaccine; 2005 Jan; 23(10):1258-64. PubMed ID: 15652668
[TBL] [Abstract][Full Text] [Related]
13. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis.
Huang X; Barrett RP; McClellan SA; Hazlett LD
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4209-16. PubMed ID: 16249500
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
Ilvesaro JM; Merrell MA; Li L; Wakchoure S; Graves D; Brooks S; Rahko E; Jukkola-Vuorinen A; Vuopala KS; Harris KW; Selander KS
Mol Cancer Res; 2008 Oct; 6(10):1534-43. PubMed ID: 18922969
[TBL] [Abstract][Full Text] [Related]
17. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis.
Mao TK; Lian ZX; Selmi C; Ichiki Y; Ashwood P; Ansari AA; Coppel RL; Shimoda S; Ishibashi H; Gershwin ME
Hepatology; 2005 Oct; 42(4):802-8. PubMed ID: 16175622
[TBL] [Abstract][Full Text] [Related]
18. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
19. Central role of endogenous Toll-like receptor-2 activation in regulating inflammation, reactive oxygen species production, and subsequent neointimal formation after vascular injury.
Shishido T; Nozaki N; Takahashi H; Arimoto T; Niizeki T; Koyama Y; Abe J; Takeishi Y; Kubota I
Biochem Biophys Res Commun; 2006 Jul; 345(4):1446-53. PubMed ID: 16730663
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
